Sitagliptin
Links shared publicly online about this topic
Liraglutide bests sitagliptin
theheart.org — “Researchers say the results support the use of liraglutide to achieve glycemic goals in patients with inadequate control on metformin.” View full resource at theheart.org
Most Recently Shared on April 23, 2010 at 9:55 pm By:
Liraglutide superior to sitagliptin when added to metformin for glycemic control: Researchers say the results supp... http://bit.ly/cCru6P
Sitagliptin linked to acute pancreatitis, FDA warns
theheart.org — “The FDA is revising prescribing information for sitagliptin and sitagliptin/metformin after cases of acute pancreatitis, some severe, surfaced in postmarketing reports.” View full resource at theheart.org
Most Recently Shared on September 28, 2009 at 5:44 pm By:
heartwire: Sitagliptin linked to acute pancreatitis, FDA warns http://bit.ly/2ZBLGp
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
fda.gov — “Cases of acute pancreatitis reported in patients treated with sitagliptin.” View full resource at fda.gov
Most Recently Shared on September 25, 2009 at 4:03 pm By:
eyeonfda Pharma and Health Lawyer
MedWatch Alert on Januvia - http://bit.ly/qkALL
Sitagliptin Approved As Add-on To Insulin
medicalnewstoday.com — “Sitagliptin (known as januvia) has been approved by the european commission as an add-on to insulin (with or without metformin) for people with type 2 diabetes who cannot control their condition e” View full resource at medicalnewstoday.com
Most Recently Shared on November 22, 2009 at 1:58 pm By:
Sitagliptin Approved As Add-on To Insulin: Sitagliptin (known as Januvia) has been approved by the European Com.. http://bit.ly/4QO9NZ
Sitagliptin Shows Anti-inflammatory Activity In Diabetics
medicalnewstoday.com — “The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level, according to data reported at the 71” View full resource at medicalnewstoday.com
Most Recently Shared on July 10, 2011 at 9:05 pm By:
Sitagliptin Shows Anti-inflammatory Activity In Diabetics http://mnt.to/3Y8p #diabetes
Sitagliptin Shows Anti-inflammatory Activity In Diabetics
medicalnewstoday.com — “The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level, according to data reported at the 71” View full resource at medicalnewstoday.com
Most Recently Shared on July 10, 2011 at 11:14 pm By:
Endocrinology Wisdom OW Health
Sitagliptin Shows Anti-inflammatory Activity In Diabetics: The dipeptidyl peptidase (DPP)-4 inhibitor sitaglipti... http://bit.ly/pxyCNx
ingentaconnect Efficacy and safety of treatment with sitagliptin or glimepiride ...
ingentaconnect.com — “ingentaconnect Efficacy and safety of treatment with sitagliptin or glimepiride ...” View full resource at ingentaconnect.com
Most Recently Shared on January 13, 2011 at 10:18 pm By:
Yvo Sijpkens MD Nephrologist, Physician, Doctor, and Internist
In patients with type 2 #diabetes sitagliptin or glimepiride led to similar improvement in glycaemic control http://bit.ly/hGFXCG
FDA warns of acute pancreatitis with sitagliptin - MPR
empr.com — “The FDA has notified healthcare professional and patients of revisions to the prescribing information for Merck's Januvia (sitagliptin tablets) and Janumet (sitagliptin/metformin tablets) to include information on reported cases of acute pancreatitis in patients treated with these medications.” View full resource at empr.com
Most Recently Shared on September 25, 2009 at 4:45 pm By:
MPR News: FDA warns of acute pancreatitis with sitagliptin: The FDA has notified healthcare profession.. http://bit.ly/18SK8N
Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin)
medicalnewstoday.com — “Merck & co., inc., which operates in many countries as merck sharp & dohme (msd), has received a positive opinion from the european medicines agency's (emea) committee for medicinal products for h” View full resource at medicalnewstoday.com
Most Recently Shared on September 26, 2009 at 11:42 am By:
MNT Clinical Trials Health News
Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin): Merck & C.. http://bit.ly/4KL2j
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 7:03 pm By:
FDA notified healthcare professionals of revisions to include information on reported cases of acute pancreatitis....http://short.to/rthu
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 4:42 am By:
FDA Alert - FDA Revises Januvia/Janumet Prescribing Information to Include Reported Cases of Acute Pancreatitis - http://bit.ly/QlRRO
Once-weekly exenatide vs daily sitagliptin or pioglitazone
theheart.org — “The investigational glucagonlike peptide-1 receptor agonist exenatide lowers hemoglobin A1C levels to a greater extent; more patients with type 2 diabetes reached A1C targets.” View full resource at theheart.org
Most Recently Shared on June 9, 2009 at 6:28 pm By:
heartwire: Once-weekly exenatide achieves better glycemic control than daily sitagliptin or pioglitazone http://bit.ly/10diDq
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain
medicalnewstoday.com — “The addition of the highly selective, once-daily dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin (Januvia), compared with glimepiride (Amaryl), to background metformin therapy provides similar” View full resource at medicalnewstoday.com
Most Recently Shared on September 20, 2010 at 3:08 pm By:
Sitagliptin Rivals Glimepiride For Glycemic Control With Less Hypoglycemia And No Weight Gain http://mnt.to/3K3V #healthnews
Sitagliptin And Simvastatin Combination - Juvisync - Approved By FDA For Diabetes With High Cholesterol
medicalnewstoday.com — “The first single tablet for both diabetes type 2 and high cholesterol, Juvisync (sitagliptin and simvastatin), has been approved by the FDA (Food and Drug Administration). Sitagliptin and simvasta” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2011 at 7:05 pm By:
MNT Cholesterol News Health News
Sitagliptin And Simvastatin Combination - Juvisync - Approved By FDA For Diabetes With High Cholesterol http://mnt.to/429R #cholesterol
Animal Model Study Suggests That Sitagliptin Can Slow The Onset Of Diabetes
medicalnewstoday.com — “Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing th” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2011 at 9:05 am By:
MNT Weight Loss News Health News
Animal Model Study Suggests That Sitagliptin Can Slow The Onset Of Diabetes http://mnt.to/3SKc #weightloss
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
